Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000018

Chief Financial Officer gave up 2,688 shares (to pay taxes)

  • Chief Financial Officer acquired 8,523 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Jonathan · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-18 Exercise or conversion : show line 1 in the form +8,523 25,641 D
2022-02-22 Shares withheld for taxes : show line 2 in the form −2,688 $29.08 $78,167 22,953 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-18 Exercise or conversion : show line 3 in the form Performance share units −8,523 8,522 D
Loading xslF345X03/wf-form4_164565063350307.xml…